Objective: A potential drawback of β blockers is their propensity to cause weight gain in
some patients. We therefore performed a systematic search of the literature regarding the …

One of the arguments put forward against the primary use of β-blockers has been concern
about adverse metabolic effects, such as unfavorable effects on lipids or insulin sensitivity …

Sharma et al1 recently published in this journal a hypothesis about a possible association
between the use of ß-blockers and weight gain. In fact, Julius et al2 reported a similar finding …

Beta‐blockers are the most frequently used drugs for the treatment of hypertension. Apart
from concerns regarding potential adverse metabolic effects on lipids or insulin sensitivity …

Background The effects of β-blockers on metabolic parameters including weight loss are
poorly understood. Methods From a database of 3582 patients who completed The Ottawa …

Linda S. Lamont, PhD Patricia Markham Risica, DrPH, RD"-blocking medications are first-
line therapy for young patients with uncomplicated hypertension. They are also prescribed to …

❏ Beta-blocker treatment reduces resting metabolic rate and may have other effects that
promote weight gain.❏ In clinical trials, weight gain of 1.2 kg was reported in the first few …

Background. Overweight and obesity often develop in individuals with genetic susceptibility
and concomitant risk factors; however, medications can represent precipitating factors in …

In this issue is presented a study by KL Leung and colleagues, 1 a post-hoc analysis of a
dataset comprising the medication profiles of a cohort of community-dwelling older adults in …

Background: Sympathetic activation is an important metabolic adaptation limiting weight
gain. Propensity of weight gain associated with β-blocker therapy in the obese modern …